Investigators and Programs

Each investigator is involved in specific fields of endocrine research and each may supervise fellows:

E. Dale Abel, MD, PhD, Mechanisms of cardiac dysfunction in diabetes

Christopher Adams, MD, PhD, Basic studies on muscle metabolism

Joseph S. Dillon, MD, Clinical studies on therapy of carcinoid and neuroendocrine tumors

Thomas M. O'Dorisio, MD, Clinical studies on therapy of carcinoid and neuroendocrine tumors

Amal Shibli-Rahhal, MD, MS, Clinical studies on bone diseases

Janet A. Schlechte, MD, Clinical studies on bone and pituitary diseases

William I. Sivitz, MD, Basic studies on mitochondrial metabolism and its role in diabetes and obesity; Clinical studies in the therapy and pathophysiology of diabetes and obesity

Mark A. Yorek, PhD, Basic studies in neurovascular complication of diabetes and obesity

There is also active clinical and research participation by faculty in other clinical and basic science departments throughout the university focused on issues that relate directly to endocrinology. Fellows are encouraged to pursue training with these individuals outside of the Division of Endocrinology if that fulfills a critical training goal for the individual. Examples of such faculty include but are not limited to the following:

Mario Ascoli, PhD, Deborah L. Segaloff, PhD, Rory Fisher, PhD, Basic mechanisms of hormone action

Frank Faraci, PhD, Curt Sigmund, PhD, Vascular function in obesity and diabetes

Ronald Weigel, MD, PhD, James Howe, MD, M. Sue O’Dorisio, MD, PhD,  Endocrine neoplasia

Eva Tsalikian, MD, Michael Tansey, MD, Intensive insulin therapies in children with type 1 diabetes

Andrew Norris, MD, PhD, Developmental origins of metabolic disease

Kamal Rahmouni, PhD,  Neuroendocrine mechanisms of obesity

See also faculty of the Diabetes Research Center and Obesity Research and Educational Initiative.